TET2 and neoplasm: TET2 mutations are observed in a larger proportion of T‐cell compared to B‐cell lymphomas [71, 72], loss of function TET2 mutations have been described in both [73, 74], suggesting a broad lineage‐independent tumor suppressor role for TET2 in lymphomagenesis.